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Poster Session II 147potentially prevent the occurrence of GVHD if it were determined
that these cells underwent sufficient homeostatic proliferation to
generate the Treg:effector T cell ratios required to accomplish
this effect. While several studies have focused on the proliferation
of transferred CD41CD251 T cells, it is well known that CD25
is also present on activated T cells, and hence is not a definitive
marker for identifying Treg. In contrast, the transcription factor,
FoxP3, has been determined to be a more definitive marker. With
this in mind, we injected unseparated CD41 T cells from C57BL/
6 (B6) GFP1FoxP3 knock-in mice into lethally irradiated B6 recip-
ients to study the proliferation and homing potential of Treg in the
context of other T cells. On days 2 and 7 post-transplant, GFP1
cells were found in the spleen of recipient mice at double the num-
ber of those found in the mesenteric lymph nodes. Furthermore, in
contrast to previously published results in which onlyCD41CD251
Tcells were injected and proliferation was reported, our experimen-
tal design should help to elucidate the fate of FoxP31 Treg under
conditions that more closely represent BMT;whereTreg constitute
part of the transferred T cell population.406
EFFECT OF IL-7 ON HUMAN NK CELLS
Michaud, A., Dardari, R., Charrier, E., Cordero, P., Duval, M. Hoˆpital
Ste-Justine, Montreal, QC, Canada.
Background: NK cells are first immune cells to reappear after
HSCT and their activation may play a role in transplantation out-
come. IL-7 is currently under clinical investigation as a therapeutic
agent after HSCT. We demonstrated that human NK cells express
IL-7 receptor, with a higher expression by CD56bright NK cells.We
thus investigated the effect of IL-7 on NK cells.Methods: Activa-
tion markers were studied by flow cytometry, as well as inhibitory
receptors expression. Proliferation assays were performed by
CFSE staining. Cytotoxicity was studied by 51Cr release assay.
Results: IL-7 induced the expression of CD25 and CD69 and en-
hanced NKG2D expression. The expression pattern of inhibitory
receptors was altered by IL-7: fewer cells expressed KIR, whereas
more cells expressed NKG2A. IL-7 induced the proliferation of
CD56bright NK cells, but not the proliferation of CD56dimNK cells.
Cytotoxicity was increased in 4 out of 7 donors. Conclusion: The
effect of IL-7 on NK cells differs from one donor to another and
from a NK cells subset to another. This must be taken into account
in the interpretation of the results of clinical trials of IL-7 after
HSCT.407
PLASMATIC TNF-a, IL-2, IFN-g AND IL-10 ARE IMPORTANT CYTOKINES
TO CONTROL CML AFTER ALLOGENEIC STEM CELL TRANSPLANT
Anjos, A.R.1, Silva, L.1, Kaneno, R.2, Calvi, S.2, Oliveira, J.S.R.1. 1Uni-
versity Federal of Sao Paulo, Sao Paulo, Brazil; 2University State of Sao
Paulo, Botucatu, Sao Paulo, Brazil.
We correlated mRNA and plasmatic TNF-a, IL-2, IFN-g and
IL-10 levels with engraftment, VOD, acute and chronic GvHD in
CML patients underwent to allogeneic BMT. There was no corre-
lation between plasmatic and mRNA cytokines during one year fol-
low-up. Plasmatic TNF-a and IL-10 were not related to acute and
chronic GvHD. In d1 30, patients suffered from acute-GvHD had
lower mRNA IL-2 and IFN-g than those without this involvement
and both were lower than controls. At d 1 360, IFN-g mRNA was
similar, IL-2 mRNA lower and plasmatic IFN-g higher than con-
trols. We showed that IL-2 mRNA is applicable to diagnosis of
chronic GvHD at d 1 180. Lately in the follow-up, we noted as
much as plasmatic TNF-a was decreased, either was IL-10; how-
ever IFN-g and IL-2 were increased. These data ruled out plasmatic
IFN- g and IL-2 as control disease cytokines that prevailed in the
chronic GvHD stable phase after allogeneic BMT.TRANSPLANT NURSING
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PERCEPTION OF KNOWLEDGE OF THE STEM CELL TRANSPLANT (SCT)
PROCESS AND EVALUATION OF SCT TEAM MEMBER FUNCTIONS BY
CAREGIVER(S): A COMPARISON BETWEEN CHILDHOOD MALIGNANT
AND NON-MALIGNANT DISORDER TRANSPLANT FAMILIES
Chadakhtzian, A.L.1, Heidotten, A.1, Yocco, M.1, Barnes, Y.J.1,
Shenoy, S.2. 1St. Louis Children’s Hospital, St. Louis, MO; 2Washington
University School of Medicine, St. Louis, MO.
Background: Allogeneic SCT recipients/families undergo edu-
cational and supportive meetings with a multi-disciplinary team
consisting of nurse coordinator, social worker, child life specialist,
financial specialist, school liaison and child psychologist. Meetings
provide education for SCT procedure. The goal is to promote un-
derstanding of benefits/risks of SCT focusing on helping families
prepare, provide medical, financial, social help and support. Aim:
Quality assessment questionnaire was developed to (1) evaluate
caregiver knowledge of process of SCT (pre-transplant testing, tox-
icities/complications of SCT, post transplant care) for the recipient
diagnosed with malignant/non-malignant disorder and (2) evaluate
perceptions of the role of multidisciplinary team.Methods: Eleven
questionnaires handed to caregivers at discharge from SCT unit to
complete and return anonymously. Questionnaires consisted of 10
questions. Each question was ranked from 1–5 with 5 being the
best. Responses scored 5 were interpreted as excellent, 3–4 consid-
ered good, 1–2 poor level of understanding requiring attention.Re-
sults: 11/11 questionnaires returned/analyzed during 2006–2007
(compliance 100%). Five returned by caregivers of SCT recipients
with malignant disorders and 6 non-malignant disorders. Care-
givers scored understanding of pre-transplant testing, toxicities,
and post transplant care between 3–5. Nurse coordinator, social
worker and child life specialist perceived most important compo-
nents of team. Nurse coordinator and child life specialist received
scores 4–5 from both groups; social worker received scores 4–5
from non-malignant group and 2–5 from malignant group. Finan-
cial specialist, school liaison, and child psychologist received scores
1–5 from both groups. Conclusions: Study suggests no difference
in perceptions of SCT process and education between families of
malignant/non-malignant disorders, and needs to be validated
with larger numbers. Results indicate families are comfortable
with medical information provided regarding SCT and social inter-
actions. The lower scoring of ancillary services suggest an incom-
plete understanding of their role perhaps due to absence of
tangible outcome measures and needs to be emphasized during
pre-transplant education.409
MAD ABOUT STEROIDS: NURSING MANAGEMENT OF THE SCT PATIENT
WITH STEROID-INDUCED PSYCHOSIS
Switzer, M.A. The University of Texas MD Anderson Cancer Center,
Houston, TX.
Prolonged courses of high dose steroids are frequently used to
manage graft vs. host disease (GVHD) following allogeneic stem
cell transplant (SCT). Among the known complications of pro-
longed steroid treatment are mental status changes, effecting up
to 40% of all transplant recipients. Five percent of these alterations
are considered ‘‘severe’’. Symptoms generally present within two
weeks of initiating high-dose therapy. Oftenmanifesting as a persis-
tent, hallucinatory state, these episodes of ‘‘steroid psychosis’’ pres-
ent significant nursing challenges. Patients can be combative,
agitated and are usually noncompliant with treatment regimes. In-
patient SCT nurses often find themselves unprepared to manage
the complex medical and psychosocial needs of patients with acute
psychosis.
Existing literature offers no standard protocols and little guid-
ance to support an evidence-based approach to the nursingmanage-
ment of SCT patients with steroid induced psychosis requiring
long-term hospitalization. A clear need exists to educate nurses co-
ordinating care for this rare but serious side effect of transplant ther-
apy. This poster will bridge the gap and provide nurses insight into
